نتائج البحث - "Adnan Khattak"

1

BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?

المؤلفون: Jeanne Tie, Jayesh Desai, Simone Steel, Vanessa Wong, Jeremy Shapiro, Margaret Lee, Peter Gibbs, Adnan Khattak, Rachel Wong, Wei Hong, Matthew Burge, Brigette B.Y. Ma, Louise M. Nott

المصدر: Targeted Oncology. 16:227-236

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::22f7d7e129140a629988bd9957af1d94Test
https://doi.org/10.1007/s11523-021-00793-7Test

2

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85Test
https://hdl.handle.net/2066/228545Test

3

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo A Secondary Analysis of a Randomized Clinical Trial

المساهمون: Medical oncology, CCA - Cancer Treatment and quality of life, AII - Cancer immunology

المصدر: Jama Oncology, 6, 519-527
Eggermont, A M M, Kicinski, M, Blank, C U, Mandala, M, Long, G V, Atkinson, V, Dalle, S, Haydon, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Krepler, C, Ibrahim, N, Marreaud, S, van Akkooi, A, Robert, C & Suciu, S 2020, ' Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial ', JAMA Oncology, vol. 6, no. 4, pp. 519-527 . https://doi.org/10.1001/jamaoncol.2019.5570Test
Eggermont, A M M, Kicinski, M, Blank, C U, Mandala, M, Long, G V, Atkinson, V, Dalle, S, Haydon, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Krepler, C, Ibrahim, N, Marreaud, S, van Akkooi, A, Robert, C & Suciu, S 2020, ' Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical Trial ', JAMA oncology . https://doi.org/10.1001/jamaoncol.2019.5570Test
Jama Oncology, 6, 4, pp. 519-527
JAMA Oncology, 6(4), 519-527. American Medical Association

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Population, Medizin, Pembrolizumab, Placebo, Antibodies, Monoclonal, Humanized, Disease-Free Survival, law.invention, Placebos, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Medicine, Humans, 030212 general & internal medicine, education, Adverse effect, Melanoma, Aged, Neoplasm Staging, Proportional Hazards Models, education.field_of_study, Manchester Cancer Research Centre, business.industry, Proportional hazards model, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, Middle Aged, Ipilimumab, Clinical trial, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b431bc34ae329792ac7bd923376806Test
https://hdl.handle.net/2066/218502Test

4

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage II Colon Cancer (DYNAMIC Trial): Statistical Analysis Plan

المؤلفون: Joshua D. Cohen, Peter Gibbs, Yuxuan Wang, Rachel Wong, Sam Harris, Jeremy Shapiro, Jeanne Tie, Bert Vogelstein, Adnan Khattak, Serigne Lo, Matthew Burge

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Standard of care, Adjuvant chemotherapy, business.industry, medicine.medical_treatment, Minimal residual disease, Clinical trial, Statistical Analysis Plan, Internal medicine, medicine, Trial registration, business, Adjuvant, Stage ii colon cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ee46293b414325f5602f6f82d1d99027Test
https://doi.org/10.1101/2021.09.02.21262816Test

5

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

المصدر: Current problems in cancer. 46(2)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0ed897b07bcfd6a00b30a5592c890dTest
https://pubmed.ncbi.nlm.nih.gov/34565601Test

6

Utilisation of geriatric assessment in oncology - a survey of Australian medical oncologists

المؤلفون: Bianca Devitt, Haryana M. Dhillon, Wee Kheng Soo, Christopher Steer, Anne Booms, Timothy To, Adnan Khattak, Jane Phillips, Heather Lane

المصدر: Journal of Geriatric Oncology. 10:216-221

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Referral, Attitude of Health Personnel, Clinical Decision-Making, Comorbidity, Physical function, Health Services Accessibility, 03 medical and health sciences, 0302 clinical medicine, Older patients, Neoplasms, Surveys and Questionnaires, Internal medicine, medicine, Humans, 030212 general & internal medicine, Cooperative Behavior, Practice Patterns, Physicians', Geriatric Assessment, Referral and Consultation, Aged, Oncologists, Polypharmacy, Frailty, business.industry, Australia, Geriatricians, Geriatric assessment, Cross-Sectional Studies, Health assessment, 030220 oncology & carcinogenesis, Respondent, Functional status, Geriatrics and Gerontology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c59f2a0a6d40ae96e50c01df48e7db0Test
https://doi.org/10.1016/j.jgo.2018.07.004Test

7

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

المساهمون: Medical oncology, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, AII - Cancer immunology

المصدر: Ann Transl Med
European Journal of Cancer, 116, pp. 148-157
European Journal of Cancer, 116, 148-157. Pergamon
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, ' Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 116, pp. 148-157 . https://doi.org/10.1016/j.ejca.2019.05.020Test
European Journal of Cancer, 116, 148-157

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, medicine.medical_treatment, Medizin, Pembrolizumab, Metastasis, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Agents, Immunological, Adjuvant therapy, AJCC-7, AJCC-8, EORTC 1325/KN-054, Melanoma, Phase III trial, Predictive factors, Prognostic factors, Adult, Aged, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Double-Blind Method, Female, Humans, Middle Aged, Neoplasm Staging, Prognosis, Treatment Outcome, Monoclonal, Humanized, Hazard ratio, Editorial Commentary, Immunological, 030220 oncology & carcinogenesis, medicine.drug, medicine.medical_specialty, Antineoplastic Agents, Ipilimumab, Antibodies, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, business.industry, Cancer, medicine.disease, 030104 developmental biology, Lymphadenectomy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e8c4fb38d782241aa3a6b2f75643c8Test
https://hdl.handle.net/2066/206244Test

8

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

المؤلفون: Adnan Khattak, Hendrik Koffijberg, Belinda Lee, Desmond Yip, Jeremy D. Shapiro, Rachel Wong, Koen Degeling, Louise M. Nott, Peter Gibbs, Maarten Joost IJzerman, Matthew Burge, Jeanne Tie, Hui-Li Wong, Stephanie H Lim, Suzanne Kosmider, Azim Jalali, Susan Caird

المساهمون: Health Services Management & Organisation (HSMO), Erasmus School of Health Policy & Management, Health Technology & Services Research, TechMed Centre

المصدر: PharmacoEconomics, 38(11), 1263-1275. Adis
PharmacoEconomics, 38(11), 1263-1275. Adis International Ltd

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb03024db52ddca17282749a2adf58eTest
https://pubmed.ncbi.nlm.nih.gov/32803720Test

9

Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status

المصدر: Clinical colorectal cancer. 20(1)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Adolescent, Colorectal cancer, Population, Kaplan-Meier Estimate, Systemic therapy, Risk Assessment, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Karnofsky Performance Status, education, Colectomy, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, Proportional hazards model, business.industry, Gastroenterology, Middle Aged, medicine.disease, Comorbidity, Progression-Free Survival, Oxaliplatin, Tumor Burden, Clinical trial, Oncology, Fluorouracil, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb92697007a2d9518b81a76a5b5473aTest
https://pubmed.ncbi.nlm.nih.gov/32919889Test

10

1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study

المؤلفون: Mohammad Alkaiyat, Adnan Khattak, A. A. Alsharm, Hakan Akbulut, Giuseppe Curigliano, Hassan Errihani, Abdul Rahman Jazieh, Christian Rolfo, R.B. De Guzman, E. Razis, Álvaro Rogado, Hoda Jradi, L.Y.I. Mula-Hussain, C. Mathias

المصدر: Annals of Oncology

مصطلحات موضوعية: medicine.medical_specialty, Oncology, Coronavirus disease 2019 (COVID-19), business.industry, Family medicine, Pandemic, Medicine, Cancer, Hematology, business, medicine.disease, Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91926fedf2431219271ea7da8eee9d05Test
https://doi.org/10.1016/j.annonc.2020.08.2325Test

تنقيح النتائج